2025
SJR Q2
JCR Q1 · 5,3
OA
928 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Enzyme Inhibition and Medicinal Chemistry
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1475636614756374
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,776
- Quartile Q2
- H-Index 103
- Atıf/yayın 5,32
- Doküman (3y) 500
- Atıf (3y) 2.782
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,3
- 5Y JIF 4,8
- JCI 1,25
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q2
- Medicine (miscellaneous) Q2
- Pharmacology Q2
Alanlar
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Biochemistry & Molecular Biology | Chemistry, Medicinal
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,776 | 5,3 | 4,8 | 1,25 | Q1 | 103 |
| 2024 | Q2 | Q1 | 0,857 | 5,4 | 4,9 | 1,36 | Q1 | 98 |
| 2023 | Q1 | Q1 | 0,949 | 5,6 | 5,1 | 1,41 | Q1 | 98 |
| 2022 | Q1 | Q1 | 0,814 | 5,6 | 5,2 | 1,26 | Q1 | 98 |
| 2021 | Q2 | Q1 | 0,749 | 5,8 | 5 | 1,32 | Q1 | 98 |
| 2020 | Q2 | Q1 | 0,916 | 5,1 | 4,6 | 1,39 | Q1 | 98 |
| 2019 | Q1 | Q1 | 0,808 | 4,7 | 3,7 | 1,28 | Q1 | 98 |
| 2018 | — | Q1 | — | 4 | 3,2 | 1,23 | Q1 | — |
| 2017 | Q1 | Q1 | 1,04 | 3,6 | 3 | 1,11 | Q1 | 98 |
| 2016 | Q2 | Q1 | 0,873 | 4,3 | 3,3 | — | — | 98 |
| 2015 | Q1 | Q1 | 1,095 | 3,4 | 2,6 | — | — | 98 |
| 2014 | Q2 | Q3 | 0,619 | 2,3 | 1,8 | — | — | 98 |
| 2013 | Q2 | Q3 | 0,645 | 2,4 | 1,8 | — | — | 98 |
| 2012 | Q2 | Q4 | 0,448 | 1,5 | 1,4 | — | — | 98 |
| 2011 | Q2 | Q3 | 0,487 | 1,6 | 1,5 | — | — | 98 |
| 2010 | Q2 | Q3 | 0,445 | 1,6 | 1,6 | — | — | 98 |
| 2009 | — | Q3 | — | 1,5 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 1,4 | 1,6 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,6 | — | — | — | — |
| 2005 | — | Q2 | — | 1,7 | — | — | — | — |
| 2004 | — | Q3 | — | 1,4 | — | — | — | — |
| 2003 | — | Q4 | — | 0,8 | — | — | — | — |
| 2002 | — | Q3 | — | 1 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 79/328 |
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q1 | 19/72 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 61/320 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 12/72 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 56/313 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 11/72 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 66/285 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 11/60 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 82/297 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 13/63 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 89/295 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 14/62 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 72/297 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 9/61 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 84/299 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 10/61 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 93/293 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 13/59 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 70/290 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 5/60 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 103/289 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 11/59 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 176/290 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 32/59 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 178/291 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 30/58 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 235/290 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 46/59 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 226/290 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 37/59 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 219/286 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 29/54 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 215/283 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 30/46 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 213/275 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/41 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 211/263 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/41 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 189/262 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 18/35 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 184/261 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 17/34 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 185/261 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 19/36 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 223/261 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/37 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 198/266 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 24/35 |